FDA Class II Recall: BD BACTEC MGIT 960 PZA Kit. IVD qualitative… by Becton Dickinson & Co.

Key facts

What this classification means

A Class II recall is FDA’s middle classification. FDA assigns Class II when use of, or exposure to, the recalled product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote. FDA still requires the recalling firm to notify affected accounts and submit status reports on the correction, though the monitoring intensity is lower than for a Class I recall. FDA's Center for Devices and Radiological Health (for devices) or Center for Drug Evaluation and Research (for drugs) reviews the classification and can require additional corrective action if the initial response is judged insufficient. Because this record is filed as Class II, professionals and consumers handling an affected lot should treat FDA's own classification -- not this page's summary of it -- as the authoritative risk signal. A Class I recall is FDA’s most serious classification. FDA assigns Class I when there is a reasonable probability that use of, or exposure to, the recalled product will cause serious adverse health consequences or death. This classification does not mean harm has already occurred in every case -- it reflects FDA’s assessment of the realistic worst-case risk profile of the defect described in the recall, based on the reason for recall reported by the firm. Class I recalls receive the closest FDA monitoring of the three classes: the recalling firm typically must submit a recall strategy, periodic status reports, and effectiveness checks confirming that the affected lots have actually been removed from distribution or corrected in the field.

What consumers should do

Facilities, clinicians, and consumers holding an affected unit or lot of BD BACTEC MGIT 960 PZA Kit. IVD qualitative procedure for susceptibility testing of Mycobacterium tuberculosis, from culture to pyrazinamide (PZA). should stop using it for the purpose described in the recall notice and hold remaining stock pending instructions from Becton Dickinson & Co.. FDA recall records typically direct the recalling firm to notify known accounts directly with a recall letter describing the specific corrective action -- replacement, field correction, refund, or return. Anyone who received the product through a distributor rather than directly from Becton Dickinson & Co. should confirm with their supplier whether their specific lot or unit is on the affected list, since recall notices are lot- or unit-specific and not every unit of a product line is necessarily included. Questions about a specific unit's status should go to Becton Dickinson & Co. directly or to the distributor that supplied it; Argus HQ is a public-record aggregator, not the recalling firm, and cannot confirm individual unit status.

Becton Dickinson & Company’s FDA history

Argus HQ has recorded 96 total FDA actions tied to Becton Dickinson & Company: 0 warning letters, 96 recalls, 0 approval records, and 0 Form 483 inspection citations.

Frequently asked questions

What is the recall class for Becton Dickinson & Co.'s recall?

FDA classified this recall as Class II. A Class II recall is FDA’s middle classification. FDA assigns Class II when use of, or exposure to, the recalled product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.

Why was BD BACTEC MGIT 960 PZA Kit. IVD qualitative procedure for su recalled?

FDA's recall record states the reason as: BD has received additional complaints of intermittent false resistance results for PZA during susceptibility testing of Mycobacterium tuberculosis isolates.

Who should I contact about this recall?

Contact Becton Dickinson & Co. directly, or the distributor/pharmacy that supplied the product, to confirm whether your specific lot or unit is affected. Argus HQ aggregates the public FDA recall record and is not the recalling firm.

Has Becton Dickinson & Co. had other FDA recalls or enforcement actions?

Yes. Argus HQ has recorded 96 total FDA actions tied to Becton Dickinson & Co., including 96 recalls and 0 warning letters.

Related enforcement actions

• Recall: Becton Dickinson & Company — Class II recall: 10mL Non-Sterile BD Luer-Lok Tip Syringe Only. Catalog Number: 301029. 850 bulk… →
• Recall: Becton Dickinson & Company — Class II recall: BD Luer Tip Caps; Catalog Number(s) or Model Number(s): 308341; →
• Recall: Becton Dickinson & Co. — Class II recall: BD Kiestra" Isolate Suspension Cuvette Array; Catalog No.: 246100; →
• Recall: Becton Dickinson & Co. — Class II recall: BD BACTEC Blood Culture System, labeled as the following: 1. BACTEC 9120 Syst… →
• Recall: Becton Dickinson & Co. — Class II recall: BD Phoenix M50 Instrument, labeled as the following: 1. BD Phoenix M50 Automa… →
• Recall: Becton Dickinson & Co. — Class II recall: BD MAX System, for in vitro diagnostic (IVD) use, labeled as the following: 1… →
• Recall: Becton Dickinson & Co. — Class II recall: BD BACTEC Blood Culture System, labeled as the following: 1. BD BACTEC FX, In… →
• Recall: Becton Dickinson & Co. — Class II recall: BD Veritor Connect Software, labeled as the following: 1. Veritor (NUC), Cata… →